(Q40207464)

18 September 2017

title

Up-regulation of tumor susceptibility gene 101 protein in ovarian carcinomas revealed by proteomics analyses (English)

1 reference

18 September 2017

Travis W Young

1

1 reference

18 September 2017

Fang C Mei

2

1 reference

18 September 2017

Daniel G Rosen

3

1 reference

18 September 2017

Gong Yang

4

1 reference

18 September 2017

Nan Li

5

1 reference

18 September 2017

Jinsong Liu

6

1 reference

18 September 2017

Xiaodong Cheng

7

1 reference

18 September 2017

publication date

16 November 2006

1 reference

Molecular & Cellular Proteomics

18 September 2017

published in

1 reference

18 September 2017

volume

6

1 reference

18 September 2017

issue

2

1 reference

18 September 2017

page(s)

294-304

1 reference

In ovarian neoplasms, BRAF, but not KRAS, mutations are restricted to low-grade serous tumours

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M600305-MCP200

Role of KRAS and BRAF gene mutations in mucinous ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M600305-MCP200

Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M600305-MCP200

Human ovarian cancer of the surface epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M600305-MCP200

Identification of Nore1 as a potential Ras effector

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M600305-MCP200

Identification of Ce-AF-6, a novel Caenorhabditis elegans protein, as a putative Ras effector

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M600305-MCP200

Identification of PLC210, a Caenorhabditis elegans phospholipase C, as a putative effector of Ras.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M600305-MCP200

Oncogenic Ras activation of Raf/mitogen-activated protein kinase-independent pathways is sufficient to cause tumorigenic transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M600305-MCP200

Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M600305-MCP200

Evidence for a Ras/Ral signaling cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M600305-MCP200

Tsg101: a novel tumor susceptibility gene isolated by controlled homozygous functional knockout of allelic loci in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M600305-MCP200

RETRACTED: The TSG101 tumor susceptibility gene is located in chromosome 11 band p15 and is mutated in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M600305-MCP200

Aberrant splicing of the TSG101 and FHIT genes occurs frequently in multiple malignancies and in normal tissues and mimics alterations previously described in tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M600305-MCP200

Low frequency of TSG101/CC2 gene alterations in invasive human breast cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M600305-MCP200

Absence of rearrangements in the tumour susceptibility gene TSG101 in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M600305-MCP200

Genomic architecture and transcriptional activation of the mouse and human tumor susceptibility gene TSG101: common types of shorter transcripts are true alternative splice variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M600305-MCP200

p53 accumulation, defective cell proliferation, and early embryonic lethality in mice lacking tsg101.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M600305-MCP200

Targeted deletion of the Tsg101 gene results in cell cycle arrest at G1/S and p53-independent cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M600305-MCP200

Tsg101 is essential for cell growth, proliferation, and cell survival of embryonic and adult tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M600305-MCP200

Cell cycle arrest and cell death are controlled by p53-dependent and p53-independent mechanisms in Tsg101-deficient cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M600305-MCP200

Molecular targets for tumour progression in gastrointestinal stromal tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M600305-MCP200

Reduction of TSG101 protein has a negative impact on tumor cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M600305-MCP200

A genetically defined model for human ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M600305-MCP200

Activation of antioxidant pathways in ras-mediated oncogenic transformation of human surface ovarian epithelial cells revealed by functional proteomics and mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M600305-MCP200

Proteomics analysis of H-RAS-mediated oncogenic transformation in a genetically defined human ovarian cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M600305-MCP200

Mass Spectrometric Sequencing of Proteins from Silver-Stained Polyacrylamide Gels

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M600305-MCP200

Silencing of H-ras gene expression by retrovirus-mediated siRNA decreases transformation efficiency and tumorgrowth in a model of human ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M600305-MCP200

A polybasic domain or palmitoylation is required in addition to the CAAX motif to localize p21ras to the plasma membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M600305-MCP200

A TSG101/MDM2 regulatory loop modulates MDM2 degradation and MDM2/p53 feedback control

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M600305-MCP200

Opposing effects of Ras on p53: transcriptional activation of mdm2 and induction of p19ARF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M600305-MCP200

Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M600305-MCP200

Ubiquitylation of MHC class I by the K3 viral protein signals internalization and TSG101-dependent degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M600305-MCP200

Tal, a Tsg101-specific E3 ubiquitin ligase, regulates receptor endocytosis and retrovirus budding

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M600305-MCP200

Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M600305-MCP200

RAS-mediated epigenetic inactivation of OPCML in oncogenic transformation of human ovarian surface epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M600305-MCP200

The essential role of Cited2, a negative regulator for HIF-1alpha, in heart development and neurulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M600305-MCP200

Transcriptional coactivator Cited2 induces Bmi1 and Mel18 and controls fibroblast proliferation via Ink4a/ARF

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M600305-MCP200

MRG1, the product of a melanocyte-specific gene related gene, is a cytokine-inducible transcription factor with transformation activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M600305-MCP200

HIF-1: master and commander of the hypoxic world. A pharmacological approach to its regulation by siRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M600305-MCP200

Targeting HIF-1 for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M600305-MCP200

Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M600305-MCP200

The potential role of hypoxia inducible factor 1alpha in tumor progression after hypoxia and chemotherapy in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M600305-MCP200

Identification of the CREB-binding protein/p300-interacting protein CITED2 as a peroxisome proliferator-activated receptor alpha coregulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M600305-MCP200

Ras-dependent induction of HIF-1alpha785 via the Raf/MEK/ERK pathway: a novel mechanism of Ras-mediated tumor promotion

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M600305-MCP200

p19ARF links the tumour suppressor p53 to Ras

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M600305-MCP200

10.1074/MCP.M600305-MCP200

21 January 2018

Identifiers

DOI

1 reference

release_hwkqbfsonvcy5ptjiz5wea5nny

18 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hwkqbfsonvcy5ptjiz5wea5nny

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference